Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2012
10/03/2012CN101851609B Porcine parvovirus L strain and use thereof in preparation of porcine parvovirus inactivated vaccines
10/03/2012CN101568647B Secretion of antibodies without signal peptides from bacteria
10/03/2012CN101365481B Canine influenza virus and related compositions and methods of use
10/02/2012US8278432 HBV drug resistance methods
10/02/2012US8278093 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
10/02/2012US8278092 Isolated reductive dehalogenase genes
10/02/2012US8277818 Herpes virus strains for gene therapy
10/02/2012CA2552949C Determination of hepatitis c virus genotype
10/02/2012CA2465895C Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
09/2012
09/27/2012WO2012127697A1 Recombinant alsv for preventing pathogenic viral infection of plant
09/27/2012US20120245029 Novel phosph(on)ate- and sulf(on)ate-based phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
09/27/2012US20120244600 Swine influenza hemagglutinin variants
09/27/2012US20120244183 Influenza viruses and uses thereof
09/27/2012US20120244180 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
09/27/2012US20120244126 Engineered enzymatically active bacteriophage and methods for dispersing biofilms
09/27/2012US20120244068 Microorganisms for imaging and/or treatment of tumors
09/27/2012CA2831125A1 Recombinant alsv for preventing pathogenic viral infection of plant
09/26/2012EP2502634A1 Herpes simplex virus combined subunit vaccines and methods of use thereof
09/26/2012CN1997746B Chimeric adenoviruses for use in cancer treatment
09/26/2012CN1902308B Method of producing baculovirus
09/26/2012CN1788088B Mutant vesicular stomatitis viruses and use thereof
09/26/2012CN102695524A Virus like particles comprising target proteins fused to plant viral coat proteins
09/26/2012CN102690792A Anti-human immunodeficiency virus (HIV) gene engineering recombinant virus and preparation method thereof, and anti-HIV gene engineering medicament
09/26/2012CN102690791A Method for generating porcine pseudorabies virus by culturing ST cell in microcarrier of bioreactor
09/26/2012CN102690790A Suspension culture production method for porcine circovirus 2-type cells
09/26/2012CN102329780B Anti-mycoplasma ST (swine testis) cell, and methods for culturing hog cholera virus low virulent strain and preparing hog cholera attenuated vaccine using same
09/26/2012CN102180951B Cholesterol modified anti-human immunodeficiency virus (HIV) polypeptide medicament and application thereof
09/25/2012US8273868 Compositions and methods for inhibiting viral replication
09/25/2012US8273564 Disinfectant composition comprising phage of Acinetobacter baumannii
09/25/2012US8273548 Nucleic acids encoding a human PAP1 polypeptide
09/25/2012US8273527 Viral variants
09/25/2012US8273344 Plasmid construct comprising cytochrome p450 oxygenase inhibitory oligonucleotides for use in prevention and treatment of cell proliferative disorders
09/20/2012WO2012125791A2 Incorporation of the b18r gene to enhance antitumor effect of virotherapy
09/20/2012WO2012125005A2 Pol i promoter derived from vero cells and recombinant vector containing same
09/20/2012WO2012122858A1 Method for producing virus-like particle by using drosophila cell and applications thereof
09/20/2012WO2012122649A1 Recombinant orf virus
09/20/2012WO2012122625A1 Method of viral production in cells
09/20/2012US20120238001 Production of viral vaccines in suspension on avian embryonic derived stem cell lines
09/20/2012US20120238000 Immortalized avian cell lines
09/20/2012US20120237999 Herpes simplex viruses and methods of viral replication
09/20/2012US20120237974 Method for the expression of a recombinant protein in a mammalian cell
09/20/2012US20120237545 Assays for influenza virus hemagglutinins
09/20/2012US20120237543 Equine rhinitis vaccine
09/20/2012US20120237527 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
09/20/2012US20120237481 Incorporation of the B18R gene to enhance antitumor effect of virotherapy
09/20/2012DE102010018961B4 Genetisch modifiziertes Paramyxovirus zur Behandlung von Tumorerkrankungen Genetically modified Paramyxovirus in the treatment of tumor diseases
09/20/2012CA2829774A1 Method of viral production in cells
09/19/2012EP2500419A1 A respiratory syncytial virus with a genomic deficiency complemented in trans
09/19/2012EP2499243A2 Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides
09/19/2012CN102676569A Novel phagemid display vector pCANTAB5M
09/19/2012CN102676516A New use of microRNA 145
09/19/2012CN102676461A Method for producing virus-like particles by utilizing drosophila cells and application
09/19/2012CN102676460A Method for vaccinating avian influenza virus through microcarrier suspension culture cell
09/19/2012CN102676415A Genetic manipulation system based on Hfx. mediterranei and pyrF gene and its application
09/19/2012CN102676414A Genetic manipulation system based on Haloarcula hispanica and pyrF gene and its application
09/19/2012CN102671194A Human vaccine for preventing hydrophobia and tetanus
09/19/2012CN102671193A Herpes simplex virus II type gene recombined attenuated live vaccine and preparation method thereof
09/19/2012CN102671192A Human diploid cell rabies vaccine and preparation method thereof
09/19/2012CN102220350B Method for expressing resveratrol stilbene synthase and preparing resveratrol by utilizing insect system
09/19/2012CN102199576B Method for separating and screening phage for degrading Pseudomonas aeruginosa biofilm
09/19/2012CN101899421B Recombinant baculovirus and construction method and application thereof
09/18/2012US8268976 Flea GABA receptor subunit nucleic acid molecules
09/18/2012US8268602 Cellular and viral inactivation
09/18/2012US8268329 Modified Vaccinia ankara virus variant
09/18/2012US8268325 Modified Vaccinia Ankara virus variant
09/18/2012CA2454750C Immunologically significant herpes simplex virus antigens and methods for using same
09/18/2012CA2252972C Serum-free production of recombinant proteins and adenoviral vectors
09/18/2012CA2221293C Helper virus-free aav production
09/13/2012US20120232133 Delivery of proteins using adeno-associated virus (aav) vectors
09/13/2012US20120231526 Method for the Purification of Alphavirus Replicon Particles
09/13/2012US20120231525 Multivalent phage display systems and methods
09/13/2012US20120231524 Chimeric adenoviruses for use in cancer treatment
09/13/2012US20120231459 Chemiluminescent probes for multiplex molecular quantification and uses thereof
09/13/2012US20120231068 Virucidal properties of various forms of sophorolipids
09/13/2012US20120227800 Biologically Self-Assembled Nanotubes
09/12/2012EP2497831A1 TB vaccination using HCMV-based vaccine vectors
09/12/2012EP2497826A1 Method of producing a temperature sensitive (ts) influenza virus
09/12/2012EP2497495A2 Making influenza virus vaccines without using eggs
09/12/2012EP2496696A1 Muteins of the bacteriophage lambda integrases
09/12/2012CN102666860A Reverse genetics systems
09/12/2012CN102666843A Wo2011079073
09/12/2012CN102666576A Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
09/12/2012CN102660545A Ribonucleic acid interference (RNAi) for inhibiting porcine reproduction and respiratory syndrome virus replication and preparation method of RNAi
09/12/2012CN102660544A Ribonucleic acid interference (RNAi) for inhibiting replication of hog cholera virus and preparation method of RNAi
09/12/2012CN102660511A Method for reducing pancreatin inhibitor in serum and application of serum
09/12/2012CN102660510A Production method of porcine transmissible gastroenteritis virus by utilizing bioreactor
09/12/2012CN102657862A Herpes simplex virus type 2 (HSV-2) genetic recombinant attenuated live vaccine and preparation method thereof
09/12/2012CN102657861A Herpes simplex virus I-type gene recombinant attenuated live vaccine and preparation method thereof
09/12/2012CN102657860A Canine parvovirus propolis inactivated vaccine and preparation method thereof
09/12/2012CN102657859A Method for producing avian influenza vaccine by using cells cultured by spherical microcarrier bioreactor
09/12/2012CN102181405B Recombinant virus and method for producing L-asparaginase II by using virus
09/12/2012CN102154369B Recombinant slow virus vector, recombinant slow virus and stem cell containing recombinant slow virus
09/11/2012US8263396 Methods and compositions for the production of recombinant virus vectors
09/11/2012US8263395 Recombinant adenoviruses preparation and adenovirus banks
09/11/2012US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
09/11/2012US8263085 Gammaretrovirus associated with cancer
09/11/2012US8263067 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy
09/11/2012CA2519112C Optimized expression of hpv 31 l1 in yeast
09/11/2012CA2451577C Gene delivery vectors with cell type specificity for mesenchymal stem cells
09/11/2012CA2326407C Retroviral vectors including modified envelope escort proteins
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 267